v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net Loss $ (987,036) $ (2,260,022)
Less loss from discontinued operations   (1,060,481)
Operating Loss from continuing operations (987,036) (1,199,541)
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value of warrant liability   (10,632,000)
Warrant issuance costs   10,420,982
Employee stock-based compensation 120,319 80,038
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (15,124) (52,520)
Accounts payable 49,421 (211,614)
Accrued expenses 48,148 100,062
Net cash used in operating activities - continuing operations (784,272) (1,494,593)
Net cash used in operating activities - discontinued operations   (165,495)
Net cash used in operating activities (784,272) (1,660,088)
Cash flows from financing activities:    
Proceeds from common stock and prefunded warrants, net   8,707,002
Net cash provided by financing activities - continuing operations   8,707,002
Net increase (decrease) in cash (784,272) 7,046,914
Cash and cash equivalents, beginning of period 5,136,722 3,709,971
Cash and cash equivalents, end of period 4,352,450 10,756,885
Less: Cash and cash equivalents attributable to discontinued operations   (1,825,831)
Cash and cash equivalents, end of period - continuing operations 4,352,450 8,931,054
Noncash Items:    
Noncash redemption of Series A Preferred Stock   338,521
Accrual of Series A Preferred Stock dividends $ 232,822 275,167
Non-cash warrant issuance costs   18,924,000
Deemed dividend on Series A Preferred Warrants   8,355,824
Accrued equity issuance costs   $ 203,984